journal article·2007-10Open access

Response of monocytes exposed to phagocytosable particles and discs of comparable surface roughness

Dong-Hwan Kim, Matt T. Novak, Jamie Wilkins, Minkyu Kim, Anita Sawyer, William M. Reichert

Biomaterials· Volume 28· Issue 29

Abstract

This in vitro study characterized the temporal cytokine expression profile from human monocytes exposed to phagocytosable Ti particles (0.78+/-0.12 microm) and to Ti discs of comparable surface roughness. Human THP-1 monocytes were cultured in six well tissue culture polystyrene (TCPS) plates. Each well was either bare, contained Ti particles (the particles were clearly engulfed by the monocytes), or contained a Ti disc. Half of the wells were treated with 1 microg/mL lipopolysaccharide (LPS), while the other half were left unstimulated. Unstimulated and LPS-stimulated cells in bare wells were the negative and positive controls, respectively. Supernatant was sampled from each well at 1, 6, 24, 48, and 72 h and assayed for the expression of nine different cytokines using a Luminex system. Three cytokines (IL-1beta, GM-CSF and IL-13) gave little to no response under all conditions, while six cytokines (TNF-alpha, IL-6, MIP-1alpha, MCP-1, VEGF, and IL-1ra) were clearly detectable. Expression levels generally increased with culture time, particle concentration, and LPS stimulation. Most significantly, it was found that cells treated by Ti discs produced in many instances a higher cytokine expression than did particles.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials · Occupational exposure and asthma

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (18)

Show source-provided references
1. Human monocyte response to particulate biomaterials generated in-vivo and in-vitro10.1002/jor.1100130520 ↗
2. Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells10.1016/S0736-0266(02)00076-1 ↗
3. Comparison of the response of human peripheral blood mononuclear cells to challenge with particles of three bone cements in vitro10.1016/S0142-9612(02)00405-2 ↗
4. Biological responses to materials10.1146/annurev.matsci.31.1.81 ↗
5. Association between periodontal and peri-implant conditions: a 10-year prospective study10.1111/j.1600-0501.2004.00982.x ↗
6. Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials10.1016/j.biomaterials.2004.06.034 ↗
7. Effects of polyethylene and a-alumina particles on IL-6 expression and secretion in primary cultures of human osteoblastic cells10.1016/S0142-9612(01)00200-9 ↗
8. Differential inflammatory macrophage response to rutile and titanium particles10.1016/j.biomaterials.2006.05.045 ↗
9. Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A.1 macrophage cell line10.1002/jbm.a.10275 ↗
10. Cell biology of hydrogels10.1016/0142-9612(93)90203-E ↗
11. Effect of particle size on macrophage-osteoclast differentiation in vitro10.1007/s007760170025 ↗
12. LPS increases biomaterial degradation by human monocytes in vitro10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J ↗
13. Thomson · 2003
14. Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways10.1128/IAI.69.7.4590-4599.2001 ↗
15. Kim DH, Smith JT, Chilkoti A, Reichert WM. The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes. Biomaterials, in press, doi:10.1016/j.biomaterials.2007.04.010.10.1016/j.biomaterials.2007.04.010 ↗
16. LPS induction of gene expression in human monocytes10.1016/S0898-6568(00)00149-2 ↗
17. Mechanisms of exocytosis in phagocytic inflammatory cells. Parke-Davis Award Lecture
18. Department of Health and Human Services. Public Health Service, Food and Drug Administration. Guideline on validation of the limulus ameboyte lysate test as an end-product endo-toxin test for human and animal parenteral drugs, biological products, and medical devices. 1987.